Wakelkamp M, Alván G, Paintaud G
Department of Medical Laboratory Sciences & Technology, Karolinska Institute, Huddinge University Hospital, Sweden.
Br J Clin Pharmacol. 1998 Jan;45(1):63-70. doi: 10.1046/j.1365-2125.1998.00637.x.
Both indirect-response models and effect-compartment models are used to describe the pharmacodynamics of drugs when there is a delay in the time course of the pharmacological effect in relation to the concentration of the drug. The aim of this study was to investigate whether the time of maximum response after single-dose administration at different dose levels could be used to distinguish between these models and to select the most appropriate pharmacokinetic-pharmacodynamic model for frusemide.
Three doses of frusemide, 10, 25 and 40 mg were given as rapid intravenous infusions to five healthy volunteers. Urine samples were collected for 5 h after dosing. Volume and sodium losses were isovolumetrically replaced with an intravenous rehydration fluid. Diuresis and natriuresis were modelled for all three doses simultaneously, applying both an indirect-response model and an effect-compartment model with the frusemide excretion rate as the pharmacokinetic input.
The observed time of maximum diuretic and natriuretic response significantly increased with dose. This increase was well predicted by the indirect-response model, whereas the modelling with the effect-compartment model led to a poor prediction of the peaks. There was no difference between the observed and predicted time of maximum diuretic and natriuretic response using the indirect-response model, whereas the time of maximum response predicted by the effect-compartment model was significantly earlier than the time observed for the 25 mg (P < 0.05) and 40 mg (P < 0.05) doses.
The time of maximum response to frusemide was better described using an indirect-response model than an effect-compartment model. Studying the time of maximum response after administration of different single doses of a drug may be used as a selective tool during pharmacokinetic-pharmacodynamic modelling.
当药理效应的时间进程相对于药物浓度存在延迟时,间接响应模型和效应室模型均用于描述药物的药效学。本研究的目的是调查在不同剂量水平下单次给药后最大反应时间是否可用于区分这些模型,并为呋塞米选择最合适的药代动力学-药效学模型。
将10、25和40mg三种剂量的呋塞米快速静脉输注给五名健康志愿者。给药后收集5小时的尿液样本。用静脉补液等容替代体积和钠的损失。以呋塞米排泄率作为药代动力学输入,同时对所有三种剂量的利尿和利钠情况应用间接响应模型和效应室模型进行建模。
观察到的最大利尿和利钠反应时间随剂量显著增加。间接响应模型能很好地预测这种增加,而效应室模型的建模对峰值的预测较差。使用间接响应模型时,观察到的和预测的最大利尿和利钠反应时间之间没有差异,而效应室模型预测的最大反应时间明显早于25mg(P<0.05)和40mg(P<0.05)剂量观察到的时间。
与效应室模型相比,使用间接响应模型能更好地描述呋塞米的最大反应时间。研究不同单剂量药物给药后的最大反应时间可作为药代动力学-药效学建模过程中的一种选择性工具。